The microbiome can serve as an important source of biomarkers for cancer types, therapy response as well as cancer treatment side-effects. In this effort, we are conducting a Microbiome in Glioma (MiG) study that aims to determine the importance of microbiome differentiating glioma grades and cancer treatment side effects. This is a team effort between the scientists at the CEABR (Drs. Shalini Jain and Hariom Yadav) and USF Neurosurgery (Drs. Anthony Patrizz and Nam Tran).

If you are interested to know more about this study, please contact us.

The Microbiome in CAncer treatment related Side Effects (MiCASE) study aims to determine the role  of gut microbiome in developing gut and mental distress reducing quality of life (QOL) in cancer survivors. It also tests an inexpensive, safe, and easy to adoptable probiotic fermented milk drink and a heat-killed postbiotics (Lactobacillus paracasei D3.5) in pragmatic open-label case-control randomized core study with a placebo arm. We are recruiting cancer survivors who are 18 years and older and have gone through cancer treatment and experiencing gut and brain related issues with poor QOL.

If you have any of concerns about your gut and brain health, please contact us:

Dr. Hariom Yadav - hyadav@usf.edu
Shalini Jain - jains10@usf.edu